Colorectal Cancer | Tumor

CURE’s colorectal cancer page is an extensive resource of cancer information featuring the latest colorectal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on colorectal cancer.

FDA Grants Designations for D3S-001 in KRAS G12C-Mutated Cancers

August 29th 2025, 3:00pm

Article

FDA grants D3S-001 treatment breakthrough therapy for KRAS G12C some with lung cancer and orphan drug status for KRAS G12C colorectal cancer in adults.

FDA Grants Breakthrough Device Status to MRD Test in Colorectal Cancer

August 26th 2025, 3:00pm

Article

The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for patients with stage 2 colorectal cancer after surgery.

Vaccine Reduces Recurrence and Death in Pancreatic, Colorectal Cancers

August 24th 2025, 6:00pm

Video

An off-the-shelf cancer vaccine is associated with durable responses and a reduced risk of relapse and death among patients with pancreatic or colorectal cancers.

FDA Approves Dako Omnis Test to Guide Colorectal Cancer Treatment

August 21st 2025, 3:00pm

Article

The FDA approved the Dako Omnis panel to identify patients with colorectal cancer with mismatch repair deficiency.

Off-The-Shelf Vaccine Elicits Durable Responses in Pancreatic, Colorectal Cancers

August 13th 2025, 9:00pm

Article

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

FDA Approves Application for ABT-301 in Metastatic Colorectal Cancer

August 4th 2025, 3:00pm

Article

The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic colorectal cancer to begin.

Can Journaling Help Heal After a Cancer Diagnosis?

July 31st 2025, 4:00pm

Article

Writing helped me focus on gratitude and healing after my colon cancer diagnosis, transforming the act into a powerful recovery tool.

Leronlimab Shows Activity in Advanced Metastatic Colorectal Cancer

July 1st 2025, 4:00pm

Article

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Zanzalintinib Combo Improves Survival in Metastatic Colorectal Cancer

June 25th 2025, 3:00pm

Article

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic colorectal cancer, phase 3 data show.

Tecentriq Plus Chemo Reduced Risk of Death vs Chemo Alone in dMMR Colon Cancer

June 1st 2025, 12:00pm

Article

Tecentriq and chemotherapy combination reduces the risk of death versus chemotherapy alone in deficient mismatch repair, stage 3 colorectal cancer.